NYU Langone Health has once more been named No. 1 within the nation for quality and patient safety by Vizient Inc., a number one healthcare performance improvement organization that determines its rankings based on mortality and infection rates, patient experience scores, and other critical quality measures. At a ceremony hosted by Vizient in Las Vegas […]
ARMGO Pharma, Inc. (ARMGO), a clinical stage biopharmaceutical company advancing a novel class of small molecule drugs generally known as Rycals®, announced today the enrollment of the primary patient in a Phase 2 proof of concept clinical trial using its Rycal ARM210 (also generally known as S48168), for the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia […]